{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:10:15Z","timestamp":1788894615338,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":1721,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1074\/mcp.m115.055095","type":"journal-article","created":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T03:27:43Z","timestamp":1451618863000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective"],"prefix":"10.1016","volume":"15","author":[{"given":"Valerie C.","family":"Wasinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunki","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizi","family":"Duo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Luber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert W.L.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M115.055095_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s11894-012-0298-9","article-title":"Inflammatory bowel disease: one or two diseases?","volume":"15","author":"Sachar","year":"2013","journal-title":"Curr. Gastroenterol. Rep"},{"key":"10.1074\/mcp.M115.055095_bib2","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1053\/j.gastro.2007.09.001","article-title":"Diagnostics of inflammatory bowel disease","volume":"133","author":"Nikolaus","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1074\/mcp.M115.055095_bib3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"10.1074\/mcp.M115.055095_bib4","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","article-title":"European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis","volume":"55","author":"Stange","year":"2006","journal-title":"Gut"},{"key":"10.1074\/mcp.M115.055095_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.16.s4.1.x","article-title":"Review article: monitoring activity in ulcerative colitis","volume":"16","author":"Rizzello","year":"2002","journal-title":"Aliment. Pharmacol. Ther"},{"key":"10.1074\/mcp.M115.055095_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/MIB.0b013e318280b19e","article-title":"Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients","volume":"19","author":"Plevy","year":"2013","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1074\/mcp.M115.055095_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.11613\/BM.2013.006","article-title":"Serological markers of inflammatory bowel disease","volume":"23","author":"Kuna","year":"2013","journal-title":"Biochem. Med"},{"key":"10.1074\/mcp.M115.055095_bib8","first-page":"162","article-title":"Clinical utility of serological markers in inflammatory bowel disease","volume":"56","author":"Mokrowiecka","year":"2009","journal-title":"Hepato-gastroenterol"},{"key":"10.1074\/mcp.M115.055095_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S1807-59322010000200015","article-title":"Non-invasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update","volume":"65","author":"Turkay","year":"2010","journal-title":"Clinics"},{"key":"10.1074\/mcp.M115.055095_bib10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/ibd.21661","article-title":"Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior","volume":"17","author":"Lichtenstein","year":"2011","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1074\/mcp.M115.055095_bib11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.crohns.2011.09.008","article-title":"Monitoring inflammatory bowel disease activity: clinical activity is judged to be more relevant than endoscopic severity or biomarkers","volume":"6","author":"Schoepfer","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"10.1074\/mcp.M115.055095_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/1354750X.2012.691553","article-title":"Biomarkers intersect with the exposome","volume":"17","author":"Rappaport","year":"2012","journal-title":"Biomarkers"},{"key":"10.1074\/mcp.M115.055095_bib13","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/jgh.12193","article-title":"Proteomics and metabolomics in inflammatory bowel disease","volume":"28","author":"Yau","year":"2013","journal-title":"J. Gastroenterol. Hepatol"},{"key":"10.1074\/mcp.M115.055095_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO;2-O","article-title":"Proteomic analysis of cytokine induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases","volume":"2","author":"Barcelo-Batllori","year":"2002","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib15","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1002\/pmic.200500541","article-title":"Comparative proteomic studies on the pathogenesis of human ulcerative colitis","volume":"6","author":"Hsieh","year":"2006","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib16","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1074\/jbc.M505986200","article-title":"Analysis of NOD2-mediated proteome response to muramyl dipeptide in HEK293 cells","volume":"281","author":"Weichart","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M115.055095_bib17","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1021\/pr060433m","article-title":"Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease","volume":"6","author":"Shkoda","year":"2007","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M115.055095_bib18","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bcp.2006.12.019","article-title":"Biomarker discovery for inflammatory bowel disease, using proteomic serum profiling","volume":"73","author":"Meuwis","year":"2007","journal-title":"Biochem. Pharmacol"},{"key":"10.1074\/mcp.M115.055095_bib19","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1002\/rcm.3323","article-title":"Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry and chemometric data analysis","volume":"21","author":"Nanni","year":"2007","journal-title":"Rapid Comm. Mass Spec"},{"key":"10.1074\/mcp.M115.055095_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cca.2013.08.016","article-title":"Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma","volume":"425","author":"Dieplinger","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/mcp.M115.055095_bib21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SA as a potential lung cancer biomarker and its involvement in metastatic pathogensis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M115.055095_bib22","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1002\/pmic.200701088","article-title":"Peptide enrichment and protein fractionation using selective electrophoresis","volume":"8","author":"Ly","year":"2008","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1074\/mcp.M114.040790","article-title":"Reverse-polynomial dilution calibration methodology extends lower limit of quantification and reduces relative residual error in targeted Peptide measurements in blood plasma","volume":"14","author":"Yau","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1074\/mcp.M113.036095","article-title":"Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach","volume":"13","author":"Carr","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib25","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The Proteomics Identifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Vizcaino","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M115.055095_bib26","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1074\/mcp.M600274-MCP200","article-title":"Experimental and statistical considerations to avoid false conclusions in proteomics studies using differential in-gel electrophoresis","volume":"6","author":"Karp","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M115.055095_bib27","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1074\/mcp.M115.055095_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1074\/mcp.M115.055095_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.yexcr.2013.07.019","article-title":"Green fluorescent protein expression triggers proteome changes in breast cancer cells","volume":"320","author":"Coumans","year":"2014","journal-title":"Exp. Cell Res"},{"key":"10.1074\/mcp.M115.055095_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1074\/mcp.M115.055095_bib31","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","article-title":"Complementing the genome with an \u201cexposome\u201d: the outstanding challenge of environmental exposure measurement in molecular epidemiology","volume":"14","author":"Wild","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"10.1074\/mcp.M115.055095_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy","year":"2011","journal-title":"Nature"},{"key":"10.1074\/mcp.M115.055095_bib33","first-page":"27","article-title":"Antibiotic treatment in inflammatory bowel disease: rifaximin, a new possible approach","volume":"3","author":"Gionchetti","year":"1999","journal-title":"Eur. Rev. Med. Pharmacol. Sci"},{"key":"10.1074\/mcp.M115.055095_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.gastro.2012.10.003","article-title":"Brain-Gut Interactions in Inflammatory Bowel Disease","volume":"144","author":"Bonaz","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1074\/mcp.M115.055095_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/ajpgi.00369.2004","article-title":"Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease","volume":"289","author":"Stadnicki","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1074\/mcp.M115.055095_bib36","first-page":"861","article-title":"Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens","volume":"74","author":"Imamura","year":"1996","journal-title":"Lab. Invest"},{"key":"10.1074\/mcp.M115.055095_bib37","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/jcb.25201","article-title":"Fibroblastic synoviocytes secrete plasma proteins via \u03b12 -macroglobulins serving as intracellular and extracellular chaperones","volume":"116","author":"Zhao","year":"2015","journal-title":"J. Cell Biochem"},{"key":"10.1074\/mcp.M115.055095_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jcb.25032","article-title":"Spp24 derivatives stimulate a Gi-protein coupled receptor-Erk1\/2 signaling pathway and modulate gene expressions in W-20\u201317 cells","volume":"116","author":"Zhao","year":"2015","journal-title":"J. Cell Biochem"},{"key":"10.1074\/mcp.M115.055095_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2012.05.002","article-title":"Decreased serum levels of nucleolin protein fragment, as analyzed by bead-based proteomic technology, in multiple sclerosis patients compared to controls","volume":"250","author":"Liu","year":"2012","journal-title":"J. Neuroimmunol"},{"key":"10.1074\/mcp.M115.055095_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/1354750X.2011.620628","article-title":"A novel marker for assessment of liver matrix remodeling: An enzyme-linked immunosorbent assay (ELISA) detecting a MMP generated type I collagen neo-epitope (C1M)","volume":"16","author":"Leeming","year":"2011","journal-title":"Biomarkers"},{"key":"10.1074\/mcp.M115.055095_bib41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10753-013-9612-4","article-title":"Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis","volume":"36","author":"Wagner","year":"2013","journal-title":"Inflammation"},{"key":"10.1074\/mcp.M115.055095_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ibd.20851","article-title":"Plasma chromogranin A in patients with inflammatory bowel disease","volume":"15","author":"Sciola","year":"2009","journal-title":"Infl. Bowel Dis"},{"key":"10.1074\/mcp.M115.055095_bib43","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-007-7254-0","article-title":"The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties","volume":"64","author":"Helle","year":"2007","journal-title":"Cell Mol. Life Sci"},{"key":"10.1074\/mcp.M115.055095_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2249.2010.04150.x","article-title":"Gut hormones: emerging role in immune activation and inflammation","volume":"161","author":"Khan","year":"2010","journal-title":"Clin. Exp. Immunol"},{"key":"10.1074\/mcp.M115.055095_bib45","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ibd.20851","article-title":"Plasma chromogranin a in patients with inflammatory bowel disease","volume":"15","author":"Sciola","year":"2009","journal-title":"Inflamm. Bowel Dis"},{"key":"10.1074\/mcp.M115.055095_bib46","doi-asserted-by":"crossref","first-page":"e4501","DOI":"10.1371\/journal.pone.0004501","article-title":"Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2","volume":"4","author":"Zhang","year":"2009","journal-title":"PlosOne"},{"key":"10.1074\/mcp.M115.055095_bib47","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.crohns.2013.04.019","article-title":"Fecal chromogranins and secretogranins are increased in patients with ulcerative colitis but are not associated with disease activity","volume":"7","author":"Strid","year":"2013","journal-title":"J. Crohns Colitis"},{"key":"10.1074\/mcp.M115.055095_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuroscience.2010.06.057","article-title":"Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders","volume":"170","author":"Bartolomucci","year":"2010","journal-title":"Neuroscience"},{"key":"10.1074\/mcp.M115.055095_bib49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-004-4461-9","article-title":"New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A","volume":"62","author":"Briolat","year":"2005","journal-title":"Cell Mol. Life Sci"},{"key":"10.1074\/mcp.M115.055095_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.regpep.2009.09.009","article-title":"Regulatory peptides from chromogranin A and secretogranin II: Putative modulators of cells and tissues involved in inflammatory conditions","volume":"165","author":"Helle","year":"2009","journal-title":"Regulatory Peptides"},{"key":"10.1074\/mcp.M115.055095_bib51","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1389203054546334","article-title":"Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system","volume":"6","author":"Fischer-Colbrie","year":"2005","journal-title":"Curr. Protein Pept. Sci"},{"key":"10.1074\/mcp.M115.055095_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(99)00033-6","article-title":"Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology","volume":"81","author":"Forte","year":"1999","journal-title":"Regulatory Peptides"},{"key":"10.1074\/mcp.M115.055095_bib53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nprot.2010.196","article-title":"Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides","volume":"6","author":"Kettenbach","year":"2011","journal-title":"Nat. Protocols"},{"key":"10.1074\/mcp.M115.055095_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1096\/fasebj.9.8.7768356","article-title":"Guanylin: a peptide regulator of epithelial transport","volume":"9","author":"Forte","year":"1995","journal-title":"FASEB J"},{"key":"10.1074\/mcp.M115.055095_bib55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1074\/jbc.270.1.431","article-title":"Isolation and molecular cloning of a novel bone phosphoprotein related in sequence to the cystatin family of thiol protease inhibitors","volume":"270","author":"Hu","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M115.055095_bib56","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.juro.2009.08.109","article-title":"Bikunin loss in urine as useful marker for bladder carcinoma","volume":"183","author":"Tsui","year":"2010","journal-title":"J. Urol"},{"key":"10.1074\/mcp.M115.055095_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/toxsci\/kfs340","article-title":"Identification of novel liver-specific mRNAs in plasma for biomarkers of drug-induced liver injury and quantitative evaluation in rats treated with various hepatotoxic compounds","volume":"132","author":"Okubo","year":"2013","journal-title":"Toxicol. Sci"},{"key":"10.1074\/mcp.M115.055095_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2119\/2008-00015.Qiang","article-title":"Purification and characterization of human adrenomedullin binding protein-1","volume":"14","author":"Qiang","year":"2008","journal-title":"Mol. Med"},{"key":"10.1074\/mcp.M115.055095_bib59","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.cgh.2013.02.030","article-title":"Histologic markers of inflammation in patients with ulcerative colitis in clinical remission","volume":"11","author":"Rosenberg","year":"2013","journal-title":"Clin. Gastroent. Hepat"},{"key":"10.1074\/mcp.M115.055095_bib60","doi-asserted-by":"crossref","first-page":"26792","DOI":"10.1074\/jbc.M512889200","article-title":"Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-a secretion in response to lipopolysaccharide","volume":"281","author":"Zernichow","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M115.055095_bib61","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1074\/jbc.M110.176461","article-title":"A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule-mediated pathway","volume":"286","author":"Melo","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M115.055095_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20061257","article-title":"Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells","volume":"403","author":"Braga","year":"2007","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M115.055095_bib63","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/jcp.55.4.298","article-title":"Expression of antimicrobial neutrophil defensins in epithelial cells of active inflammatory bowel disease mucosa","volume":"55","author":"Cuncliffe","year":"2002","journal-title":"J. Clin. Pathol"},{"key":"10.1074\/mcp.M115.055095_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2249.2003.02035.x","article-title":"Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis","volume":"131","author":"Fahlgren","year":"2003","journal-title":"Clin. Exp. Immunol"},{"key":"10.1074\/mcp.M115.055095_bib65","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcb.24376","article-title":"Secreted phosphoprotein-24 kDa (Spp24) attenuates BMP-2-stimulated Smad 1\/5 phosphorylation and alkaline phosphatase induction and was purified in a protective complex with alpha2 -Macroglobulins From Serum","volume":"114","author":"Zhao","year":"2013","journal-title":"J. Cell Biochem"},{"key":"10.1074\/mcp.M115.055095_bib66","doi-asserted-by":"crossref","first-page":"e72645","DOI":"10.1371\/journal.pone.0072645","article-title":"Secreted Phosphoprotein 24 kD (Spp24) and Spp14 affect TGF-\u00df induced bone formation differently","volume":"8","author":"Tian","year":"2013","journal-title":"Plos One"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033721X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153594762033721X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M115.055095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:51:51Z","timestamp":1761526311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153594762033721X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S153594762033721X"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m115.055095","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Mass Blood Peptides Discriminative of Inflammatory Bowel Disease (IBD) Severity: A Quantitative Proteomic Perspective","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M115.055095","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}